Bruker (NASDAQ:BRKR – Get Free Report) issued its quarterly earnings results on Tuesday. The medical research company reported $0.70 EPS for the quarter, topping the consensus estimate of $0.65 by $0.05, MarketWatch Earnings reports. Bruker had a net margin of 11.32% and a return on equity of 32.20%. The business had revenue of $844.50 million […]
Bruker (NASDAQ:BRKR – Get Free Report) released its earnings results on Tuesday. The medical research company reported $0.70 earnings per share for the quarter, topping the consensus estimate of $0.65 by $0.05, MarketWatch Earnings reports. Bruker had a return on equity of 32.20% and a net margin of 11.32%. The business had revenue of $844.50 […]
Bruker (NASDAQ:BRKR – Get Free Report) issued its earnings results on Tuesday. The medical research company reported $0.70 EPS for the quarter, beating the consensus estimate of $0.65 by $0.05, MarketWatch Earnings reports. Bruker had a net margin of 11.32% and a return on equity of 32.20%. The firm had revenue of $844.50 million during […]
Bruker (NASDAQ:BRKR – Get Free Report) had its price objective hoisted by Stifel Nicolaus from $63.00 to $81.00 in a note issued to investors on Wednesday, Benzinga reports. The firm currently has a “hold” rating on the medical research company’s stock. Stifel Nicolaus’ target price points to a potential upside of 5.48% from the stock’s […]
New York State Common Retirement Fund reduced its position in shares of Bruker Co. (NASDAQ:BRKR – Free Report) by 6.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 253,815 shares of the medical research company’s stock after selling 17,016 shares […]